作者:
Naik,M.G. [1]
;
Heller,K.M. [2]
;
Arns,W. [3]
;
Budde,K. [4]
;
Diekmann,F. [5]
;
Eitner,F. [6]
;
Fischereder,M. [7]
;
Go?mann,J. [8]
;
Heyne,N. [9]
;
Morath,C. [10]
;
Riester,U. [11]
;
Gwinner,W. [12]
;
Jürgensen,J.S.
作者单位:
Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany
[1]
Pfizer Pharma GmbH, Berlin, Germany
[2]
Department of Medicine IV, University Hospital LMU, Munich, Germany
[3]
Transplant, Centre Cologne, Cologne General Hospital, Cologne, Germany
[4]
Transplant Care Centre Frankfurt, Frankfurt, Germany
[5]
Department of Nephrology, Charité University - Mitte, Berlin, Germany
[6]
Division of Nephrology, Department of Medicine, University of Erlangen, Erlangen, Germany
[7]
Section of Nephrology and Hypertension, Department of Internal Medicine IV, Tübingen University
[8]
Hospital Clinic, Barcelona, Spain
[9]
Department of Nephrology, Hannover Medical School, Hannover, Germany
[10]
Department of Nephrology, Charité University - Virchow, Berlin, Germany
[11]
Department of Nephrology, University of Heidelberg, Heidelberg, Germany
[12]
发布时间
2015-03-11